Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions

NCT02173379 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02173379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02173379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2014
Completion date
April 6, 2022
Enrollment
2,604 (actual)
Sites
120

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary artery stenosis, coronary disease, coronary stenosis